Introduction {#sec1-1}
============

The first case of rabbit hemorrhagic disease virus (RHDV) in Egypt was recorded in Sharkia Province in 1991, and this disease has since spread to other Egyptian governorates \[[@ref1]\]. Despite active vaccination programs, RHDV remains a threat to farms that produce rabbit meat for popular consumption \[[@ref2]\] because of high disease-associated morbidity and mortality.

Rabbit hemorrhagic disease (RHD) is a rapidly fatal viral disease of adult rabbits. The first recorded clinical cases of RHD were in China \[[@ref3]\]. The disease spread rapidly through Asia and Europe and became endemic within just few years \[[@ref4]-[@ref6]\]. The etiological agent, RHDV, is a member of the Calicivirus family. Typically, RHDV kills more than 90% of susceptible adult animals within 2-3 days of infection \[[@ref6]\]. In 2010, a new strain, RHDV2, was identified in association with infection of rabbits of different ages and populations in France \[[@ref7]\]. RHDV2 spread rapidly throughout Europe \[[@ref8],[@ref9]\] and was detected in Australia in 2015 \[[@ref10]\] and in Canada in 2016 \[[@ref11]\]. RHDV2 is now considered endemic in Europe \[[@ref12]\]. The disease associated with RHDV2 includes symptoms that are similar to those of classic RHDV, although mortality rates are comparatively low \[[@ref13]\]. Transmission of RHDV can be through oral, nasal, and conjunctival routes, and transmission through a vector-like insect has been reported \[[@ref14]\]. Transmission of RHDV may also occur through direct contact with an infected animal as infected rabbits may shed the virus in their excretions \[[@ref15]\]. The pathogenesis of RHD includes development of petechial hemorrhages in multiple systemic organs as a result of virus-induced hyper-coagulopathy, and the most severe form of these lesions appear in the liver, trachea, and lungs \[[@ref16]\]. RHDV also promotes fatal hepatitis, most notably in adult rabbits \[[@ref7]\]. RHDV2 can result in fatal infections of rabbits at different ages, including those as young as 11 days old \[[@ref17]\]. This new lagovirus has also been detected in wild hares \[[@ref18],[@ref19]\]. The combination of classical and variant viruses by definition has resulted in increased diversity in this virus species \[[@ref20],[@ref21]\]. The genomic structures of RHDV and RHDV2 are similarly arranged, and both include two open reading frames (ORFs). ORF1 encodes the nonstructural proteins, including the RNA-dependent RNA ­polymerase and the major capsid protein (VP60). The second ORF encodes a minor structural protein known as *vp10* \[[@ref22],[@ref23]\]. Many polymerase chain reaction (PCR)-based methods are available for the identification of viruses, including rabbit viruses, and these methods are substantially more rapid than traditional virus isolation as they offer the possibility of high throughput with improved sensitivity and specificity. PCR also facilitates virus gene sequencing so that all vaccine and wild-type virus strains can be fully typed and differentiated. PCR can also be used for the detection of pathogens that are difficult to be isolated using traditional methods and those that are present in low titer in test samples \[[@ref24]\]. The virus *VP60* gene has been selected as a target \[[@ref25]\] for reverse-transcription PCR (RT-PCR) assay which is currently used as a general screening tool for rabbit and hare caliciviruses. The *VP60* gene was also used for the development of a universal RT-PCR method for detecting lagoviruses that uses primers that span a highly conserved region \[[@ref26]\].

The aim of the current study was to identify circulating RHDV strains found in distinct populations of rabbits in Egypt. Our goal is to use molecular analyses to determine the relationship of any new isolates to the strains currently used for the critical vaccination strategies.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

This study does not contain any experimental studies with animals. Diseased rabbits were euthanized before sampling in accordance with the regulations of the General Organization for Veterinary Services and Animal Health Research Institute.

Study period and location {#sec2-2}
-------------------------

The study was performed during 2018-2019 along 15 representative Governorates.

Sample collection {#sec2-3}
-----------------

Lung and liver samples were collected from 10 rabbits per flock after intravenous administration of 3-5 mg/kg xylazine and 35-40 mg/kg ketamine to facilitate euthanasia. All tissue samples were collected from all freshly killed rabbits. The surveyed populations were of various ages and sexes. All samples were collected aseptically, placed in sterile bags, and transported to the lab on dry ice for further laboratory evaluation. The samples were collected from rabbits in 15 different Egyptian governorates, as listed in [Table-1](#T1){ref-type="table"}.

###### 

The sources of examined samples for RHDV.

  No.     Egyptian governorates   Total no of rabbits in flocks   No of examined suspected flock   Source of samples                 
  ------- ----------------------- ------------------------------- -------------------------------- ------------------- -------- ---- ---------
  1\.     Cairo                   100                             4                                1                   unvacc   3    unvacc
  2\.     Giza                    209                             6                                1                   unvacc   5    unvacc
  3\.     Fayom                   74                              4                                1                   unvacc   3    unvacc
  4\.     Kaliobia                36                              2                                1                   unvacc   1    unvacc
  5\.     Behira                  205                             3                                0                   0        3    2 vacc
  6\.     Sharkia                 385                             5                                2                   unvacc   3    3 vacc
  7\.     Gharbia                 290                             7                                2                   unvacc   5    1 vacc
  8\.     Menofia                 23                              2                                1                   unvacc   1    unvacc
  9\.     khafr el Sheikh         60                              2                                1                   unvacc   1    unvacc
  10\.    Alex                    40                              1                                0                   0        1    unvacc
  11\.    Dakhlia                 107                             4                                0                   0        4    unvvacc
  12\.    Menia                   96                              5                                3                   unvacc   2    unvacc
  13\.    Sohag                   60                              1                                0                   0        1    unvacc
  14\.    Assuit                  71                              3                                1                   unvacc   2    unvacc
  15\.    Qina                    20                              1                                0                   0        1    unvacc
  Total                           1776                            50                               14                  \-       36   6 vacc

RHDV=Rabbit hemorrhagic disease virus

Hemagglutination assay (HA) {#sec2-4}
---------------------------

An HA was performed according to previously published methods \[[@ref27]\]. Briefly, a fragment of liver tissue was mechanically homogenized in 10-20% (w/v) saline solution (pH 7.2), followed by clarification of the supernatant by centrifugation at 5000 g for 10 min. Type O human red blood cells (RBCs; VACSERA, Cairo, Egypt) were washed in phosphate-buffered saline (PBS; pH 6.5) and then subjected to centrifugation at 500 g for 10 min. The sedimented erythrocytes were re-suspended at 0.75% concentration in PBS (pH 7.2). HA was performed with serial two-fold dilutions of clarified liver homogenate in 50 ml PBS, pH 7.2, and positive and negative controls were also included. Fifty microliters of 0.75% washed type O human RBCs were added to each well, followed by incubation at 4°C for 1 h. The HA titer was determined according to the reciprocal of the highest dilution capable of generating hemagglutination of the RBCs.

RNA extraction {#sec2-5}
--------------

RNA extraction from the clarified tissue homogenates was performed using the QIAamp viral RNA Mini kit (Qiagen, Gmbh, Germany) according to the manufacturer's instructions. Briefly, 140 µl of the supernatant was incubated with 560 µl of AVL lysis buffer and 5.6 µl of carrier RNA at room temperature for 10 min. After incubation, 560 µl of 100% ethanol was added. The sample was then washed and centrifuged 2 times. RNA was eluted with 60 µl of elution buffer.

PCR amplification {#sec2-6}
-----------------

Oligonucleotide primers (Metabion, Germany) that were designed \[[@ref28]\] to amplify 538 bp of the *VP60* gene (P33: CCACCACCAACACTTCAGGT and P34: CAGGTTGAACACGAGTGTGC) were used in a 25 µl reaction containing 12.5 µl of Quantitect probe RT-PCR buffer (Qiagen, Gmbh, Germany), 1 µl of each of the primers at a concentration of 20 pmol, 0.25 µl of reverse transcriptase, 7.25 µl of water, and 3 µl of RNA template. The reaction was performed in a Biometra thermal cycler. Reverse transcription was carried out at 50°C for 30 min, followed by a primary denaturation step at 95°C for 15 min, 35 cycles of 94°C for 30 s, 56°C for 40 s, and 72°C for 45 s. A final extension step was performed at 72°C for 10 min.

Analysis of the PCR products {#sec2-7}
----------------------------

Fifteen microliters of the amplified *VP60* PCR products were evaluated by gel electrophoresis using ultrapure 1.5% agarose (Invitrogen, Thermo Fisher Scientific, Germany) in 1×Tris-borate-EDTA (TBE) buffer at room temperature. Gelpilot 100 bp DNA ladder (Qiagen, Gmbh, Germany) was used to determine fragment sizes. PCR-amplified bands were detected by imaging using a gel documentation system (Alpha Innotech, Biometra). Data were analyzed using Automatic Image Capture Software (Protein Simple, formerly Cell Biosciences, San Jose, CA, USA).

Gene sequencing {#sec2-8}
---------------

### Genetic and phylogenetic analyses {#sec3-1}

PCR products were purified using a QIAquick PCR Product extraction kit (Qiagen, Gmbh, Germany). Sequence reactions were performed using a Bigdye Terminator V3.1 cycle sequencing kit (Perkin-Elmer), and purification was performed using Centri-Sep spin columns (Thermo Fisher, Germany). VP60 sequences were obtained using a 3130 genetic analyzer (Applied Bio-systems, Life technologies, Thermo Fisher, Germany). Basic Local Alignment Search Tool (BLAST^®^) \[[@ref29]\] alignment was performed to establish sequence similarities to the sequences deposited in the GenBank database. The MegAlign module of Lasergene DNA-Star ver­sion 12.1 was used to determine phylogenetic dis­tances among the analyzed strains \[[@ref30]\], and MEGA6 was used to create a phylogenetic tree using max­imum composite likelihood with 1000 bootstrap replications, neighbor-joining, and maximum parsi­mony \[[@ref31]\].

Results {#sec1-3}
=======

In this study, the diagnosis of suspected RHDV cases was determined based on disease-associated clinical signs, postmortem lesions, HA activity, conventional PCR, and sequencing of the RHDV *VP60* gene. A total of 50 rabbit herds were initially identified as suspected RHDV, and this suspicion was based on records of sudden death in rabbit flocks associated with neurologic and respiratory signs together with liver necrosis and generalized petechial hemorrhages in multiple tissues as revealed by postmortem examination. These animals surveyed from 15 different governorates in Egypt. Only six flocks of female rabbits had been vaccinated against RHDV, and all 16 rabbits ultimately diagnosed for RHDV were from flocks that were unvaccinated ([Table-1](#T1){ref-type="table"}, Supplementary Tables-[S1](#T2){ref-type="table"} and [S2](#T3){ref-type="table"} and [Figure-1](#F1){ref-type="fig"}).

###### 

Collection data for positive samples.

  Sample   Age        Governorate   Sample           Collection date   Sex      Quantitative plate HA result   HA titer   Vaccination status   No. of rabbits
  -------- ---------- ------------- ---------------- ----------------- -------- ------------------------------ ---------- -------------------- ----------------
  1        3 weeks    Kaliobia      Lung and Liver   March 2018        Male     \+                             2^12^      Unvacc               20
  2        12 weeks   Faium         Liver            July 2019         Female   \+                             2^10^      Unvacc               12
  3        8 weeks    Menia         Lung and Liver   July 2019         Male     \+                             2^14^      Unvacc               30
  4        6 weeks    Sharkia       Liver            June 2018         Male     \+                             2^11^      Unvacc               35
  5        4 weeks    Sharkia       Liver            June 2018         Male     \+                             2^13^      Unvacc               50
  6        7 weeks    Menia         Liver            July 2019         Male     \+                             2^12^      Unvacc               18
  7        6 weeks    Assiut        Lung and Liver   July 2019         Female   \+                             2^16^      Unvacc               20
  8        2 weeks    Menofia       Lung and Liver   July 2019         Male     \+                             2^12^      Unvacc               5
  9        8 weeks    Gharbia       Liver            February 2019     Female   \+                             2^9^       Unvacc               10
  10       10 weeks   Qena          Lung and Liver   April 2019        Female   \+                             2^14^      Unvacc               20
  11       18 days    Dakahlia      Lung and Liver   April 2019        Female   \+                             2^11^      Unvacc               30
  12       9 weeks    Assiut        Lung and Liver   January 2019      Male     \+                             2^11^      Unvacc               40
  13       10 weeks   Sohag         Liver            August 2018       Female   \+                             2^13^      Unvacc               60
  14       12 weeks   Behira        Liver            February 2019     Female   \+                             2^14^      Unvacc               25
  15       6 weeks    Faium         Liver            December 2018     Female   \+                             2^10^      Unvacc               20
  16       8 weeks    Menia         Liver            August 2018       Female   \+                             2^12^      Unvacc               9

HA=Hemagglutination assay

###### 

Collection data for negative samples.

  Sample   Age        Governorate    Sample           Collection date   Sex      Vaccination status   No. of rabbits
  -------- ---------- -------------- ---------------- ----------------- -------- -------------------- ----------------
  1        4 weeks    Cairo          Lung and Liver   May 2019          Male     Unvacc               50
  2        10 weeks   Cairo          Lung and Liver   May 2019          Female   Unvacc               30
  3        3 weeks    Cairo          Lung and Liver   May 2019          Female   Unvacc               10
  4        1 month    Cairo          Lung and Liver   May 2019          Female   Unvacc               10
  5        3 weeks    Giza           Lung and Liver   December 2018     male     Unvacc               15
  6        19 days    Giza           Lung and Liver   November 2018     Female   Giza-2006            100
  7        2 months   Assiut         Liver            July 2019         Female   Unvacc               11
  8        1 month    Behira         Lung and Liver   February 2019     Female   Giza-2006            120
  9        3 months   Kaliobia       Lung and Liver   March 2018        Female   Unvacc               16
  10       2 months   Menia          Lung and Liver   August 2018       Female   Unvacc               27
  11       1 month    Menia          Lung and Liver   August 2018       Male     Unvacc               12
  12       7 weeks    Gharbia        Liver            February 2019     Male     Unvacc               40
  13       3 months   Gharbia        Liver            February 2019     Female   Giza-2006            150
  14       1 month    Giza           Lung and Liver   May 2019          Female   Unvacc               40
  15       5 weeks    Giza           Lung and Liver   May 2019          Female   Unvacc               30
  16       2 weeks    Giza           Lung and Liver   May 2019          Female   Unvacc               9
  17       3 months   Giza           Lung and Liver   May 2019          Female   Unvacc               15
  18       2 months   Kafrelsheikh   Lung and Liver   January 2019      male     Unvacc               20
  19       5 weeks    Behira         Lung and Liver   April 2019        Female   Giza-2006            60
  20       6 weeks    Kafrelsheikh   Lung and Liver   March 2019        Female   Unvacc               50
  21       9 weeks    Alex           Lung and Liver   June 2019         Female   Unvacc               40
  22       2 weeks    Menofia        Lung and Liver   February 2019     Female   Unvacc               18
  23       17 days    Gharbia        Liver            January 2019      Female   Unvacc               22
  24       3 months   Gharbia        Liver            January 2019      male     Unvacc               31
  25       1 month    Gharbia        Liver            January 2019      Female   Unvacc               20
  26       6 weeks    Gharbia        Liver            January 2019      Female   Unvacc               7
  27       7 weeks    Dakahlia       Lung and Liver   October 2018      Female   Unvacc               27
  28       2 months   Dakahlia       Lung and Liver   October 2018      Female   Unvacc               30
  29       1 month    Dakahlia       Lung and Liver   October 2018      Female   Unvacc               20
  30       5 weeks    Sharkia        Lung and Liver   June 2018         Female   Giza-2006            90
  31       3 months   Sharkia        Lung and Liver   June 2018         Female   Giza-2006            70
  32       20 days    Sharkia        Lung and Liver   June 2018         Female   Giza-2006            200
  33       9 weeks    Faium          Lung and Liver   December 2018     Female   Unvacc               18
  34       5 weeks    Faium          Lung and Liver   December 2018     Male     Unvacc               24

![Egyptian epidemiological map for rabbit hemorrhagic disease virus (RHDV) according to the geographical distribution during (2018-2019). The classical form of RHDV virus appeared as red dots, while RHDV2 appeared green triangle and mainly distributed in the lower Egypt \[Source: <https://www.d-maps.com>\].](Vetworld-13-1098-g001){#F1}

As shown in [Figure-1](#F1){ref-type="fig"}, the flocks that were RHDV-positive were from the upper Egyptian governorates, and those diagnosed with RHDV2 were from the lower Egyptian provinces.

VP60 PCR {#sec2-9}
--------

A specific 538 bp band encoding a fragment of the virus *VP60* gene was amplified by PCR in 16 of the 50 rabbit herds tested (32%). Fifty percent of the males tested were found to be RHDV-positive, in contrast to only 25% of females tested ([Table-2](#T4){ref-type="table"}).

###### 

Incidence of RHDV in both examined sexes.

  Sum of no. of cases   Cases             
  --------------------- ------- ---- ---- ----
  Female                27      9    36   25
  Male                  7       7    14   50
  Grand total           34      16   50   32

RHDV=Rabbit hemorrhagic disease virus

HA activity {#sec2-10}
-----------

All of the 16 samples from RHDV-PCR-positive rabbits also tested positive for HA activity. HA titers varied from 2^9^ to 2^16^.

DNA sequencing {#sec2-11}
--------------

DNA sequencing of the *VP60* amplicons revealed a range of 78.4-100% nucleotide sequence identity. Sequence analysis indicated that two distinct RHDV types were circulating in different districts in Egypt. A sequence from one set of amplicons was closely related to that of the classical G3-G5 strains, and the other set of amplicons was more closely related to RHDV2 ([Figure-2](#F2){ref-type="fig"}). The new sequences were assigned GenBank accession numbers MN295014-MN295029. In 2018, both RHDV genotypes (RHDV group G3-G5 and RHDV2) were detected equally. In 2019, RHDV2 was identified more frequently, as shown in [Table-3](#T5){ref-type="table"}. The overall nucleotide sequence identity with the Egyptian RHDV-vaccine strains (GenBank accessions numbers KX133721.1 and JQ995154.1) ranged from 78.8% to 91.1%.

![The phylogenetic tree of sequenced strains (AZ1 and AZ16) and other randomly selected strains form GenBank (MEGA 6 -- neighbor-joining and maximum parsimony tool) \[[@ref31]\].](Vetworld-13-1098-g002){#F2}

###### 

A collective data for the positive cases with reference to the year of detection, governorates and strain type.

  Flock no   Age        Age group           Governorate   Sex      Collection date   Genbank acc. no. and code   Genogroup                 Quantitative plate HA result   HA titer
  ---------- ---------- ------------------- ------------- -------- ----------------- --------------------------- ------------------------- ------------------------------ ----------
  1          3 weeks    \<2 months          Kaliobia      Male     March 2018        MN295014 AZ1                RHDV2                     \+                             2^12^
  2          12 weeks   2 months and more   Faium         Female   July 2019         MN295015 AZ2                Classic RHDV Genogroup5   \+                             2^10^
  3          8 weeks    2 months and more   Menia         Male     July 2019         MN295016 AZ3                Classic RHDV Genogroup5   \+                             2^14^
  4          6 weeks    \<2 months          Sharkia       Male     June 2018         MN295017 AZ4                RHDV2                     \+                             2^11^
  5          4 weeks    \<2 months          Sharkia       Male     June 2018         MN295018 AZ5                RHDV2                     \+                             2^13^
  6          7 weeks    \<2 months          Menia         Male     July 2019         MN295019 AZ6                Classic RHDV Genogroup5   \+                             2^12^
  7          6 weeks    \<2 months          Assiut        Female   July 2019         MN295020 AZ7                Classic RHDV Genogroup5   \+                             2^16^
  8          2 weeks    \<2 months          Menofia       Male     July 2019         MN295021 AZ8                RHDV2                     \+                             2^12^
  9          8 weeks    2 months and more   Gharbia       Female   February 2019     MN295022 AZ9                RHDV2                     \+                             2^9^
  10         10 weeks   2 months and more   Qena          Female   April 2019        MN295023 AZ10               Classic RHDV Genogroup5   \+                             2^14^
  11         18 days    \<2 months          Dakahlia      Female   April 2019        MN295024 AZ11               RHDV2                     \+                             2^11^
  12         9 weeks    2 months and more   Assiut        Male     January 2019      MN295025 AZ12               Classic RHDV Genogroup5   \+                             2^11^
  13         10 weeks   2 months and more   Sohag         Female   August 2018       MN295026 AZ13               Classic RHDV Genogroup5   \+                             2^13^
  14         12 weeks   2 months and more   Behira        Female   February 2019     MN295027 AZ14               RHDV2                     \+                             2^14^
  15         6 weeks    \<2 months          Faium         Female   December 2018     MN295028 AZ15               Classic RHDV Genogroup5   \+                             2^10^
  16         8 weeks    2 months and more   Menia         Female   August 2018       MN295029 AZ16               Classic RHDV Genogroup5   \+                             2^12^

RHDV=Rabbit hemorrhagic disease virus, HA=Hemagglutination assay, PCR=Polymerase chain reaction

Most cases of RHDV were detected during the summer months. In 2018, infections were detected at the highest frequency (50%) during the month of August. By contrast, in 2019, 83% of RHDV infections were detected in July.

The phylogenetic tree is notable for clear clustering of the two distinct virus genotypes, and these groups can be distinguished from the two aforementioned vaccine strains, as shown in [Figure-2](#F2){ref-type="fig"}.

Epidemiological findings {#sec2-12}
------------------------

The sequence data revealed that there are presently two genotypes of RHDV circulating in distinct regions and governorates within Egypt. As shown in [Figure-1](#F1){ref-type="fig"}, the geographical distribution of the ­circulating strains of the RHDV virus showed that genotypes associated with the classical RHDV strain (G3-G5) were concentrated mainly in upper Egypt, and those associated with RHDV2 circulated in lower Egypt.

The RHDV-positive samples were divided into two groups according to the age of the rabbit host (\<2 months vs. ≥2 months of age). As shown in [Table-4](#T6){ref-type="table"}, classical RHDV genotype samples represented 75% of the older group, while RHDV2 samples represented 62.5% of the younger group.

###### 

The difference between age groups in relation to the detected RHDV strains.

  Age groups                            Classic RHDV Genogroup (5)   RHDV2 (variant)   Total positive   \% of classical   \% of variant RHDV-2
  ------------------------------------- ---------------------------- ----------------- ---------------- ----------------- ----------------------
  2 months and more (8 weeks or more)   6                            2                 8                6/8=75            2/8=25
  \<2 months (\<8 weeks)                3                            5                 8                3/8=37.5          5/8=62.5
  Total                                 9                            7                 16               9/16=56.3         7/16=43.7

RHDV=Rabbit hemorrhagic disease virus, HA=Hemagglutination assay, PCR=Polymerase chain reaction

Discussion {#sec1-4}
==========

According to an 2017 report from the Food and Agriculture Organization of the United Nations, Egypt is one of the five major producers of rabbit meat, where Italy was the fifth largest producer of rabbit meat in the world, following China, the Democratic People's Republic of Korea, Spain, and Egypt \[[@ref32]\]. In the early 1990s, RHDV was classified as a member of the family Caliciviridae \[[@ref33],[@ref34]\], genus *Lagovirus* \[[@ref6]\]. The virus is typically highly contagious among rabbits of different species and ages \[[@ref35],[@ref36]\], and infection with the virus can result in sudden death that is typically associated with liver necrosis and acute hepatitis \[[@ref37],[@ref38]\] with generalized congestion and hemorrhage \[[@ref39],[@ref40]\]. In this study, we identified 16 cases that were positive for RHDV using PCR, and these 16 cases were hemagglutinin-positive, with titers ranging from 2^9^ to 2^16^. These results are consistent with those reported previously \[[@ref13]\] that indicated that RHDV2 efficiently agglutinates human type O RBCs and confirmed the use of HA as a routine diagnostic tool for the detection of RHDV2 in infected samples. Conventional RT-PCR was used to detect RNA of RHDV from liver and lung samples, and 16 out of 50 cases (32%) of suspected RHDV were revealed as positive by this method. The sampled cases were from 15 Egyptian governorates and were collected in 2018-2019. The classical RHDV strain was identified primarily in localities within upper Egypt, and RHDV2 was detected primarily within the governorates of the lower Egypt. Overall, the detection of the circulating strains of both RHDV and RHDV-2 is consistent with findings reported previously \[[@ref12]\] regarding RHDV2 as the dominant circulating strain in both wild and domestic rabbits. Interestingly, the disease associated with the RHDV2 variant manifests in a similar fashion to that caused by classical RHDV, although the mortality rates may be more variable and tend to be lower \[[@ref13]\].

An initial analysis of genetic diversity among these strains was initiated by comparing partial sequences from a few RDHVs isolated from European countries \[[@ref41],[@ref42]\]. Our results are consistent with those reported in a previous study \[[@ref43]\], in which rabbits \<28 days old were found to be susceptible to RHDV disease. In this study, the samples were collected from rabbits at different ages and during different seasons. The group that tested positive was divided into those \<2 months of age and those ≥2 months of age, as shown in [Table-3](#T5){ref-type="table"}. Classical RHDV was detected in three out of eight cases of the younger age group, while five cases tested positive for RHDV2. However, in the older age group, six of the eight rabbits (75%) tested pos­itive for classical RHDV. An earlier publication, \[[@ref44]\] discussed the fact that many clinical cases have been recorded from different governorates within Egypt, with clinical signs consistent with acute RHD, and these results suggested that the two strains might have comparatively equal virulence during natural RHDV outbreaks. Regarding the seasonality of this disease, most of the cases in our study were detected during the summer season, most notably in the month of July ([Figure-3](#F3){ref-type="fig"}). By contrast, other reports \[[@ref45]\] noted that RHDV was identified in rabbits during the spring of 1991 in Sharkia Province associated with 90% losses. RHDV was also reported during the winter and spring of 1993 in upper Egypt (Minya, Assiut, and Sohag Provinces), with mortality rates from 26.7% to 100% among 14-16 week-old rabbits. Amplification, sequencing, and phylogenies of the *VP60* gene from all incidents, in addition to the immunological typing of the virus material from three cases, confirmed the presence of RHDV2 \[[@ref43]\].

![The distribution of positive cases in proportion to the total examined with relation to the month and year of detection (2018-2019) in Egypt.](Vetworld-13-1098-g003){#F3}

In this study, we amplified a 538 bp fragment of the *VP60* gene, and this has been reported to be highly conserved among RHDV variants. Our findings are consistent with those reported earlier \[[@ref25]\] regarding the efficacy of *VP60* as a target for PCR assays and as a general screening tool for rabbit and hare caliciviruses. The *VP60* gene was used to develop universal *Lagovirus* PCR primers that span a highly conserved region within RHDV \[[@ref26]\]. Results from another study \[[@ref46]\] revealed that the viral *VP60* gene was targeted to explore all rabbit lagoviruses circulating in Australia. Here, we used these primers exclusively for the primary screening of animals for suspected RHDV infections. Among our findings, the *VP60* sequences from our study were most closely related to those from 2010 to 2012 RHDV2 isolates from France, Spain, and Portugal with 97%-98% nucleotide sequence identity \[[@ref47]\]. Interestingly, RT-PCR primers targeting the *VP60* gene sequence were also used for the detection of several distinct species of lagoviruses, including the European brown hare syndrome virus and rabbit calicivirus \[[@ref26]\].

The study analyzed the phylogeny of 16 RHDV strains detected in 2018 and 2019 from 15 different provinces in Egypt, and amplification and sequencing of a fragment of the *VP60* capsid gene from virus cDNA resulted in the identification of novel virus strains with nucleotide identities ranging from 78.4% to 100%. Among our main conclusions, we found that the two major RHDV strains, namely, RHDV and RHDV2, were circulating in different regions of Egypt. One of these strains was the classical G3-G5 RHDV, and the other strain was variant-type RHDV2 (GenBank accessions numbers MN295014-MN295029).

The rabbit industry is of importance in the production of both meat and fur, and as such, it needs to focus on ways to prevent viral, bacterial, and parasitic diseases \[[@ref22],[@ref48],[@ref49]\]. Our results confirm infections with different strains of RHDV that is circulating concurrently within Egypt, and these viruses infect both male and female rabbits within various age groups. Our results also suggest that the current vaccine strain may not be sufficient in protecting against all strains currently in circulation. As such, research into future vaccination strategies is stressed here.

In the current study, RT-PCR amplification of a fragment of the *VP60* gene confirmed the presence of RHDV RNA in liver and lung samples of 16 cases out of 50 total suspected cases (32%), suggesting a high incidence of this disease. These findings are similar to those reported in earlier Egyptian studies \[[@ref50]\] that focused on the examination and detection of the RHDV *VP60* gene from 20 liver homogenates from infected rabbits during an earlier virus outbreak in Egypt (2015 to 2016). In this earlier study, four isolates were among the classical RHDV strains, and only one isolate was identified as a variant. The cases were identified in various Egyptian governorates in 2018-2019. Our findings revealed a high distribution and significant circulation of both the classical and variant virus strains within Egyptian rabbit populations.

DNA sequence analysis resulted in the classification into two genotypes, specifically classic RHDV and variant RHDV2. To the best of our knowledge, these variant RHDV2 strains have not been detected previously in Egypt. As such, this presents a new challenge and threat to the rabbit industry in Egypt. The classical strain was circulating primarily in localities within upper Egypt. However, the new European RHDV2 variant was identified within the governorates of lower Egypt. This result is somewhat to be expected as the lower Egyptian governorates are much closer to some of the European countries such as France, where the variant strain was first recorded. Some authors claim that RHDV2 has become the dominant strain circulating in Europe, and it may have already replaced older RHDV strains and accounts for most of the reported cases in wild and domestic rabbits \[[@ref12]\]. The disease associated with RHDV2 variant includes similar manifestations as those seen in response to an infection with one of the classical strains, although mortality rates are variable \[[@ref13]\].

The initial characterization of RHDV genetic diversity was initiated by sequencing and comparing partial *VP60* sequences with related isolates from European countries. One research group \[[@ref16]\] reported that the classic virus strains typically cause disease in rabbits older than 2 months of age. The results of our study revealed that both genotypes can infect rabbits of different ages. Another previous report \[[@ref44]\] noted that clinical cases of acute RHDV from different Egyptian governorates demonstrated similar virulence to cases of previously reported natural RHDV outbreaks. Most of our cases were detected in the summer season, most notably in the month of July, as shown in [Figure-3](#F3){ref-type="fig"}. An earlier report \[[@ref45]\] mentioned that RHD had been reported during the spring of 1991 in Sharkia Province, with 90% losses, and also during the winter and spring of 1993 in upper Egypt (Minia and Sohag governorates), with mortality rates of 26.7%-100% in 14-16-old rabbits. Subsequent outbreaks have occurred in other governorates, including Kaliobia \[[@ref51]\] and Assuit \[[@ref52]\].

Conclusion {#sec1-5}
==========

In this study, we reported the detection of two distinct genotypes of RHDV among rabbits of different ages and both genders. We are quite concerned to confirm the emergence and near-dominance of the RHDV2 variant in rabbit populations throughout Egypt. These findings underscore the urgent need to launch a new vaccine that is capable of protection against both circulating genotypes.
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